Literature DB >> 1787648

Histopathologic findings associated with a chronic, progressive decline in renal allograft function.

B L Kasiske1, R S Kalil, H S Lee, K V Rao.   

Abstract

The relationship between specific histopathologic findings of chronic rejection (CR) and the clinical course of renal transplant recipients with a chronic progressive decline in allograft function (CPDAF) is unknown. We used one or two hinged regression lines, fitted by least-squares to serial creatinine clearances, to define the onset and clinical course of CPDAF. Biopsies (N = 100) from patients transplanted from 1978 to 1982 were studied retrospectively. Interstitial fibrosis, tubular atrophy, and fibrointimal arterial narrowing were more pronounced in biopsies obtained after, but not before the onset of CPDAF. Interstitial hemorrhage, an infrequent finding in acute vascular rejection, preceded the onset of CPDAF, but the more common histologic findings of acute cellular rejection did not. The severity of histologic features of CR (as reflected by a score combining fibrointimal arterial narrowing, interstitial fibrosis, tubular atrophy, glomerular sclerosis, glomerular mesangial expansion, and glomerular basement membrane reduplication) correlated with the duration of subsequent allograft survival (r = -0.65, P less than 0.001). Glomerular size increased after transplantation, but was not different in patients with or without CPDAF, suggesting that mechanisms related to compensatory hypertrophy did not play a major role in the pathogenesis of CR. In summary, the histologic findings of CR did not predict the onset of CPDAF, did not distinguish whether the pathogenesis was mediated by immune or nonimmune events, but did correlate with the duration of subsequent allograft survival.

Entities:  

Mesh:

Year:  1991        PMID: 1787648     DOI: 10.1038/ki.1991.240

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  [Immunologic, alloantigen-dependent factors in chronic graft rejection].

Authors:  C Barth; J Stachowski; A von Menges; P Lammerding; C A Baldamus
Journal:  Med Klin (Munich)       Date:  1998-01-15

Review 2.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.

Authors:  K Blakolmer; A Jain; K Ruppert; E Gray; R Duquesnoy; N Murase; T E Starzl; J J Fung; A J Demetris
Journal:  Transplantation       Date:  2000-06-15       Impact factor: 4.939

4.  Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis.

Authors:  A J McLaren; S V Fuggle; K I Welsh; D W Gray; P J Morris
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

5.  Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.

Authors:  Negar Azarpira; M Bagheri; Gh A Raisjalali; M H Aghdaie; S Behzadi; H Salahi; M Rahsaz; M Darai; M J Ashraf; B Geramizadeh
Journal:  Mol Biol Rep       Date:  2008-05-03       Impact factor: 2.316

Review 6.  Through a glass darkly: seeking clarity in preventing late kidney transplant failure.

Authors:  Mark D Stegall; Robert S Gaston; Fernando G Cosio; Arthur Matas
Journal:  J Am Soc Nephrol       Date:  2014-08-05       Impact factor: 10.121

Review 7.  Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.

Authors:  Titte R Srinivas; Herwig-Ulf Meier-Kriesche
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

8.  Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.

Authors:  Wai H Lim; Brigitte Adams; Stephen Alexander; Antonia H M Bouts; Frans Claas; Michael Collins; Elisabeth Cornelissen; Heather Dunckley; Huib de Jong; Lloyd D'Orsogna; Anna Francis; Sebastiaan Heidt; Jean Herman; Rhonda Holdsworth; Joshua Kausman; Rabia Khalid; Jon Jin Kim; Siah Kim; Noël Knops; Vasilis Kosmoliaptsis; Cynthia Kramer; Dirk Kuypers; Nicholas Larkins; Suetonia C Palmer; Chanel Prestidge; Agnieszka Prytula; Ankit Sharma; Meena Shingde; Anne Taverniti; Armando Teixeira-Pinto; Peter Trnka; Francis Willis; Daniel Wong; Germaine Wong
Journal:  BMC Nephrol       Date:  2021-12-19       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.